Company Data
Cartesian Therapeutics Inc.
Ticker
RNAC
Current Price
$8.26 -0.84%
Market Cap
$242.7M
Price Target
Refer to Report
Volume
145.3K
52wk Range
$5.6 - $14.56
Overview
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.